An International Summit in Human Genetics and Genomics- Aug 28th - Sept. 28th, 2019

Summit date- August 28 - September 28, 2019 

Application deadline- December 2010 ,2018

Eligibility- healthcare professionals and trainees from developing nations that are in their early-mid careers

The Human Genome Project (HGP), led by the National Human Genome Research Institute (NHGRI) at NIH, was the world's largest, government sponsored, collaborative, biological project that led to the development of a reference sequence for the human genome. This effort benefitted both medical research and the practice of medicine worldwide, as it provided new insights into the genetic contributions to disease.

Many scientists and consortia are now working on collecting data on variations in human genes and their association with disease (e.g. Human Variome Project, UNESCO, ClinVar, ExAC etc.). It is anticipated that these efforts will help find new, improved and cost-effective approaches for the diagnosis, treatment and prevention of disease, thereby reducing the burden of disease and disability, and alleviating the economic stress attributed by these conditions on the world's most vulnerable populations.

This Summit is a 5-year initiative (2016-2020) designed to help developing nations build and expand their knowledge base, infrastructure, systems, research efforts and technologies in human genetics and genomics. Increasing their access to these resources will help them build capacity in these areas and will help resource-poor countries address their public health challenges in genetic diseases. This will ultimately help build healthier nations worldwide.

Eligibility and Application

The program is intended to train healthcare professionals and trainees from developing nations that are in their early-mid careers. The curriculum is designed in English for healthcare professionals with an advanced understanding of the biological sciences. Hence, research scientists (Ph.D.), physicians (M.B.B.S./M.D.), dentists (D.D.S./D.M.D.), dentist-scientists, nurses (M.S./Ph.D.), counselors (M.S./Ph.D.) and medical, dental and graduate school trainees can apply. Selected candidates will be fully sponsored (travel, local transportation in the United States, lodging and per diem) for the duration of the summit (Aug 28th - Sept. 28th, 2019). Participants will share lodging quarters with another participant (same sex) to reduce costs. Attendance on all days and of all events is required. Self-sponsorship may be possible, provided seats are available.

In order to measure the success of this program, candidates will be required to participate in:

• A pre- and post-survey to each day's curriculum and at the end of the Summit.
• An intermediate report (1-2 years, as determined) on their professional development and career choices and advancements in genomics.
• Follow-up reports every year to measure their ability to successfully integrate their learning in research and practice, by:
  • The number of collaborations established and publications.
  • Systems established to record, track and monitor the occurrence and re-occurrence of congenital birth defects and genetic diseases.
  • Number of cases identified, diagnosed and treated.
  • Number of cases referred for counseling and for medical management of the condition.
  • Improvement in the quality of life of affected individuals and their families.
  • The multiplier effect resulting from their return to their countries to build capacity (train others, set up research/clinical facilities, introduce genomics in the curriculum etc.) and strengthen their curricula, research and healthcare systems.

Interested and qualified candidates must apply on official letterhead and signatures, with:

1. Resume/ Curriculum Vitae
2. Cover letter, not to exceed 2 pages indicating-

• Their interest in attending the Summit.
• Specification of the area in which 'tailored' training is desired, based on interests and needs.
• The impact the Summit will have on their careers, in Genetics and Genomics.
• Plans to implement the knowledge gained to address the public health challenges specific to their nation.
• Their ability and commitment for continued evaluation over a 5-year period.

3. Three letters of recommendation on official letterhead signed by-

• Immediate supervisor
• Head/Chair of the Department
• Dean of Institution
• Vice Chancellor of the University
• Employer
• Professors for trainees currently in medical or graduate school

For more information, visit https://www.genome.gov/27563951/an-international-summit-in-human-genetics-and-genomics/ 

How to Apply:

We are now accepting applications for the 2019 Summit. A 'complete' application package must be submitted via email to mkaur@mail.nih.gov  by December 10, 2018. Selections are on a rolling basis and seats are limited so please apply early. Incomplete applications will not be considered.

U.S.-JAPAN COOPERATIVE MEDICAL SCIENCES PROGRAM COLLABORATIVE AWARDS -CRDF GLOBAL

CRDF Global is accepting proposals from joint U.S., Japan, and other regional Asia-Pacific (APac) based investigators working in the field of infectious disease and immunology research for the U.S.-Japan Cooperative Medical Sciences Program (USJCMSP) Collaborative Awards, 2019. This initiative is jointly funded by CRDF Global utilizing funds provided by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) and the Japan Agency for Medical Research and Development (AMED). USJCMSP Collaborative Awards, 2019 is the third round of a collaborative award program that was initiated in 2016 following the 50th anniversary celebration of the USJCMSP. The awards program aims to promote the inclusion of early-stage and female scientists in collaborative research.

Proposal Deadline: Saturday, December 15, 2018

ELIGIBILITY

Individuals who served as PIs on the 2016 or 2018 USJCMSP collaborative awards cannot apply as PIs in this competition.

All proposals must meet each of the following eligibility criteria:

1) Each proposal must include one PI from each sub-team (U.S., Japan and/or APac team) who will serve together as Co-PIs of the collaborative team. Co-PIs will share overall responsibility for the project and coordinating all project participants and institutions. The institution at which each PI is employed will serve as the individual team’s Principal Institution[1] designated on the proposal. Additional Investigators and institutions may be included as secondary collaborators to each individual team at the discretion of the co-PIs.

2) Each PI must:

• Possess the degree of Ph.D., M.D., or the equivalent research experience 
• Demonstrate scientific capacity and research experience. 
• Be employed at an institution that can serve as the Principal Institution on the award. 

3) On each application it is strongly encouraged that both of the Japanese sub-team and the U.S. sub-team include as a PI an early-stage or female investigator. At least either of the Japanese sub-team or the U.S. sub-team must include an early-stage or female investigator as a PI. In applications that include a collaborating APac sub-team, the APac sub-team must include at least ONE early-stage or female investigator, preferably as the APac sub-team PI. If senior investigators (i.e., non-early-stage) are included as members of the proposed Japanese, U.S. or APac sub-teams, at least one senior investigator involved in each project must be identified as a mentor and trainer who will work with the early-stage investigator(s) involved in each project.

4) Sub-team budget allocation percentages must total 100% for the collaborative team and may not exceed $60,000 USD.

Investigators from the United States, Japan, and other APac countries are invited to jointly apply for funding for collaborative research projects focused on the areas of research listed below and other related topics. Basic and clinical immunology and endemic and emerging infectious diseases relevant to the APac region eligible for this competition are the following:

• Acute Respiratory Infections
• Cholera and other Bacterial Enteric Diseases
• Hepatitis
• Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)
• Immunology related to Infections Diseases
• Nutrition and Metabolism (related to Infectious Diseases and/or Immunology)
• Parasitic Diseases
• Resistance against Anti-Microbial/Viral Agents
• Tuberculosis, Leprosy, and other Mycobacteria
• Other Viral Diseases
• Other Emerging and Reemerging Diseases

More information here: http://www.crdfglobal.org/funding-opportunities/2019-USJCMSP 

Grand Challenges Explorations - Increasing Demand for Vaccination Services (BMGF)

Increasing Demand for Vaccination Services (Round 22)

THE CHALLENGE

Within this call to increase demand for vaccination services, and thus increase the number of children vaccinated globally, we are looking for innovative ideas in the following specific areas (please specify whether your concept applies to the first, or second challenge, or both):

(1) Novel approaches for providing practical knowledge about vaccines and vaccination services to caregivers

(2) Novel ideas for improving the convenience and/or caregiver seeking of vaccination services

Additionally, we will consider proposals in low-income countries that:

• Are based on human-centered design principles
• Utilize latest thinking in social, economic, and behavioral research
• Do not increase burden upon frontline health workers
• Minimize perverse incentives (including incentives for falsification)
• Are relevant in multiple developing country settings
• Constitute transformative rather than incremental improvements and are deliverable and scalable in low-income countries

Key features of the GCE initiative are:
• A two-page application.
• Rapid turnaround time. We select projects within approximately five months of the proposal
submission.
• Blinded and champion-based review process. Reviewers with a track record in identifying
innovative ideas select the proposals they find most pioneering without need for consensus.
• Awards of $100,000 USD are made in Phase I. Phase I awardees have one opportunity to apply
for a follow-on Phase II award of up to $1,000,000 USD.

INDIRECT COSTS
Project funds may not be used to pay any indirect costs.

Key Dates 
September 2018: Application period opens
Application deadline: Wednesday, November 14, 2018, 11:30 a.m. US Pacific Standard Time
February 2019: Proposal review completed
April 2019: Selections completed, and notifications sent
May 2019: Awarded projects start date

Eligibility Criteria
GCE is open to both foreign and domestic organizations, including non-profit organizations, for-profit companies, international organizations, government agencies, and academic institutions.

Links:

https://gcgh.grandchallenges.org/challenge/increasing-demand-vaccination-services-round-22

https://gcgh.grandchallenges.org/sites/default/files/additional-materials/GCE_Rules_and_Guidelines_Round22.pdf

Grassroots Initiative Grants for People Living with HIV (EJAF)

Through the Fund for Key Populations in Eastern Europe and Central Asia, the Foundation and partners support initiatives benefiting the populations most-at-risk for HIV in this region.

Type of projects: Projects providing tangible impacts on individuals living with and communities affected by HIV Aids 
Location: Cameroon, Cote D’Ivoire, Ghana, India, Indonesia, Kenya, Lesotho, Malawi, Myanmar (Burma), Nigeria, Russian Federation, South Africa, Tanzania, Thailand, Uganda, Ukraine, United Kingdom, Vietnam, Zambia and Zimbabwe
Eligibility: UK and Southern CSOs can apply
Grant range: £10,000 - £15,000 (approx. 428,300 Thai Baht)


ROBERT KEY MEMORIAL FUND

Open to organisations that can demonstrate an immediate, tangible benefit for individuals living with HIV.

Must not exceed £10,000 per year

 Can be for 1 or 2 years in length
 Must provide an immediate and tangible benefit to People Living with HIV
 Proposals must be for a specific project and demonstrate a clear need for support
 We do not fund salary costs solely (salary costs may however be included as part of the budget of an overall project)

Types of programmes we would consider under the Robert Key Memorial Fund are:
- Small scale interventions or projects working with People Living with HIV
- Projects that fight stigma and discrimination against People Living with HIV
- Immediate services such as urgent care or medical interventions for PLHIV

Types of programmes we would not support under the Robert Key Memorial Fund are:
- Prevention of Mother to Child Transmission (PMTCT)
- Awareness raising/prevention
- Behaviour change
- Programmes that re-grant or provide sub-grants to other organisations
- General running/operational costs for your organisation
- Research Projects

Deadline:
This fund is open for application all year round.

Links:

https://london.ejaf.org/grants/#our+grants

https://london.ejaf.org/wp-content/uploads/2015/08/RKMF-Grant-Criteria.pdf

Global Infectious Disease Research Training Program (GID) NIH

Funding Opportunity Announcement (FOA) Number: PAR-18-840

D43 International Research Training Grants

Companion Funding Opportunity:  PAR-17-058 D71 International Research Training Planning Grant

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) encourages applications for the Global Infectious Disease (GID) Research Training Program from U.S. and low- and middle-income country (LMIC) institutions. The application should propose a collaborative training program that will strengthen the capacity of an LMIC institution to conduct infectious disease research. FIC will support research-training programs that focus on major endemic or life-threatening emerging infectious diseases, neglected tropical diseases, infections that frequently occur as co-infections in HIV infected individuals or infections associated with non-communicable disease conditions of public health importance in LMICs.

This Funding Opportunity Announcement (FOA) allows support of trainees as the lead investigator of an independent clinical trial; or a separate ancillary study to an existing trial; or to gain research experience in a clinical trial led by another investigator, as part of their research and career development. 

Program Objectives

The objectives of the Global Infectious Disease Research Training program are:

- To develop research training opportunities and career development activities for a cadre of LMIC scientists and health research professionals to strengthen the capacity to conduct independent, sustainable infectious disease research at a LMIC institution.

- To provide mentored training-related infectious disease research experience that is directly relevant to the health priorities of the LMIC.

- To strengthen the capabilities of trainees at LMIC institutions to lead, manage and train others in infectious disease research.

 The training program should provide:

• A strong foundation in research design, methods, and analytic techniques appropriate for the proposed infectious disease research area;
• The enhancement of the LMIC trainees' ability to conceptualize and think through research problems with increasing independence;
• Experience conducting infectious disease research using state-of-the-art methods as well as trainees presenting and publishing their research findings;
• The opportunity to interact with members of the scientific community at appropriate scientific meetings and workshops; and
• The enhancement of the LMIC trainees' understanding of the health-related sciences and the relationship of their research training to health and disease.

The Global Infectious Disease Research Training programs should be designed to move beyond training numbers of people for the next career level to demonstratively increasing sustainable, independently resourced infectious disease research capacity at the proposed LMIC institution.  It is expected that the training strategies employed will contribute to measurable enhancement of defined infectious disease research capacity outcomes.

The proposed institutional infectious disease research training program may complement other ongoing research training and career development programs at the applicant institution, but the proposed program must be clearly distinct from related programs.

Eligibility
Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Award Budget
Applications budgets are limited to $230,000 per year for new awards and $276,000 per year for renewal awards (total direct costs).

Award Project Period
The maximum project period is up to 5 years.  

Key Dates
Open Date (Earliest Submission Date): June 26, 2018  

Letter of Intent Due Date(s): 30 days prior to the application due date  

*Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Expiration Date: July 26, 2019

Inquiries

Scientific/Research Contact

Barbara Sina, Ph.D.Program Director
Division of International Training and Research
Fogarty International Center
National Institutes of Health
Building 31, Room B2C39
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: (301) 402-9467
FAX: (301) 402-0779
Email: barbara_sina@nih.gov

Grants Management Contact

Satabdi RaychowdhuryGrants Management Specialist
Fogarty International Center
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Satabdi.Raychowdhury@nih.gov

Award Budget

(D43) Applications budgets are limited to $230,000 per year for new awards and $276,000 per year for renewal awards (total direct costs).
(D71) Applications budgets are limited to $46,000 (total direct costs).

Award Project Period
(D43) The maximum project period is 5 years.
(D71) The maximum project period is 1 year.  

*Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Deadline

Application Due Date(s)

July 26, 2019, by 5:00 PM local time of applicant organization.  All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.

Full details: https://grants.nih.gov/grants/guide/pa-files/PAR-18-840.html

Ecology and Evolution of Infectious Diseases Initiative (EEID)

Status: Accepting applications

Apply through NSF program solicitation- https://www.nsf.gov/pubs/2018/nsf18581/nsf18581.htm#toc 

Program Overview

This joint National Institutes of Health (NIH) - National Science Foundation (NSF) initiative supports efforts to understand the underlying ecological and biological mechanisms that govern relationships between human-induced environmental changes and the emergence and transmission of infectious diseases. The highly interdisciplinary research projects funded under this program apply both ecological and biomedical methods, and study how environmental events such as habitat alteration, biological invasion, climate change, and pollution alter the risks of emergence and transmission of viral, parasitic, and bacterial diseases in humans and other animals. Projects are encouraged to consider how integrated environmental and biomedical approaches to infectious diseases may enhance our ability to predict and control them.

Eligibility: 

Who May Submit Proposals:

The categories of proposers eligible to submit proposals to the National Science Foundation are identified in the NSF Proposal & Award Policies & Procedures Guide(PAPPG), Chapter I.E.

Who May Serve as PI:

There are no restrictions or limits.

Limit on Number of Proposals per Organization:

There are no restrictions or limits.

Limit on Number of Proposals per PI or Co-PI: 2

In a given year, an individual may participate as a PI, co-PI, or sub-award lead on no more than two proposals submitted in response to this solicitation. This limit does not include RCN proposals. In addition, an individual from Israel may participate in no more than oneUS-BSF proposal and an individual from China may participate in no more than one US-China proposal. Proposals in excess of the limit for any person will be returned without review in the reverse order received. Participating in a proposal as other senior personnel does not count in this limit. Changes in investigator roles post-submission to meet the eligibility limits will not be allowed. It is the responsibility of the submitters to confirm that the entire team is within the eligibility guidelines.

Deadlines

• Upcoming application deadline: November 21, 2018
• Estimated future deadlines: third Wednesday in November, annually

Recent Awards

• View a full list of NIH EEID Awards
• View a full list of NSF EEID Awards

More information

https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269

Inquiries

Programmatic Issues

Dr. Christine Jessup
Program Officer
Fogarty International Center
National Institutes of Health
Building 31, B2C39
31 Center Drive MSC 2220
Bethesda, MD 20892-2220
Phone: (301) 496-1653
Fax: (301) 402-0779
Email: Christine.Jessup@nih.gov

Grants Management

Mollie Shea
Grants Management Specialist
Fogarty International Center
National Institutes of Health
Building 31, Room B2C29
31 Center Drive, MSC 2220
Bethesda, MD 20892-2220
Telephone: 301-496-9750
Fax: 301-594-1211
Email: Mollie.Shea@nih.gov

Fogarty Emerging Global Leader Award

Program Overview

The Fogarty Emerging Global Leader Award aims to provide research support and protected time to a research scientist from a LMIC who holds an academic junior faculty position or research scientist appointment at an LMIC academic or research institution. Low-income, lower-middle-income and upper-middle-income countries are included.

Applications are invited from LMIC research scientists from any health-related discipline who propose both critically needed career development activities and a research project that is highly relevant to the health priorities of their country.

Status: Accepting applications

Eligibility

• Some current and former NIH PDs/PIs are not eligible, as specified in the May 31, 2017 notice of change in eligibility (NOT-TW-17-004).
• Updated Notice of change in eligibility (NOT-TW-18-002), released November 8, 2017
• Only low- or middle-income country (LMIC) institutions are eligible.
• Income categories are defined by The World Bank Country and Lending Groups .
• Country eligibility for Fogarty International Training Grants applies.
• Candidates must be LMIC citizens.
• Candidates must hold an academic junior faculty position or research scientist appointment at the LMIC applicant institution and must have been in this position for at least one year at the time the application is submitted.
• Candidates are required to have both U.S. and LMIC primary mentors.
• Research should take place primarily in the LMIC.
• Individuals who have already received independent research funding are not eligible.
• Applicants should demonstrate that they are committed to an independent research career and justify the need for three to five years of mentored research experience in order to become an independent research scientist.
• View full eligibility details in the program announcement and refer to FAQs.

Deadlines

• Letter of Intent due dates: 30 days before the application due date​
• Upcoming application due date: November 7, 2018

Recent Awards

View a list of Emerging Global Leader awards by institution.

Frequently Asked Questions

​Access answers to frequently asked questions (FAQs) about the Fogarty Emerging Global Leader Award

.
More information- https://www.fic.nih.gov/Programs/Pages/emerging-global-leader.aspx?utm_source=funding-news&utm_medium=email&utm_campaign=funding-news